Ticker > Company >

Hemant Surgical Inds share price

Hemant Surgical Industries Ltd.

  21.26 K   66   5 BSE: 543916 SECTOR: Medical Equipment/Supplies/Accessories

650.00
+21.35 (3.40%)
BSE: 06 Nov 04:01 PM

Price Summary

Today's High

₹ 650

Today's Low

₹ 603

52 Week High

₹ 679

52 Week Low

₹ 215

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 944.94 Cr.

Enterprise Value

₹ 950.78 Cr.

No. of Shares

1.45 Cr.

P/E

51.83

P/B

6.03

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  107.79

CASH

₹ 43.83 Cr.

DEBT

₹ 49.66 Cr.

Promoter Holding

52.83 %

EPS (TTM)

₹  12.54

Sales Growth

116.84%

ROE

19.18 %

ROCE

19.64%

Profit Growth

124.22 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year116.84%
3 Year28.39%
5 Year31.05%

Profit Growth

1 Year124.22%
3 Year33.65%
5 Year73.94%

ROE%

1 Year19.18%
3 Year19.35%
5 Year28.49%

ROCE %

1 Year19.64%
3 Year22.03%
5 Year28.83%

Debt/Equity

0.3906

Price to Cash Flow

-29.51

Interest Cover Ratio

6.9538

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2026 52.83 0.00
Mar 2026 58.90 0.00
Sep 2025 58.90 0.00
Jun 2025 58.90 0.00
Mar 2025 73.56 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 28.3874670878578% for the Past 3 years.
  • Company has been maintaining healthy ROCE of 22.0298% over the past 3 years.
  • Company’s PEG ratio is 0.651625808882372.
  • The company has an efficient Cash Conversion Cycle of 36.1392 days.
  • The company has a high promoter holding of 52.83%.

 Limitations

  • Company has negative cash flow from operations of -32.0227.
  • The company is trading at a high EV/EBITDA of 31.5836.

Quarterly Result (All Figures in Cr.)

 Quarterly Data is not available for this company.Report us

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales 103.57 109.15 105.61 106.53 230.99
Total Expenditure 97.27 98.6 95.14 97.19 207.59
Operating Profit 6.3 10.55 10.47 9.34 23.39
Other Income 2.2 2.35 4.31 4.97 5.73
Interest 1.64 1.99 0.97 2.33 3.97
Depreciation 0.75 0.85 1.03 1.42 1.52
Exceptional Items 0 0 0 0 0
Profit Before Tax 6.11 10.06 12.78 10.56 23.63
Tax 1.5 2.42 2.98 2.42 5.4
Net Profit 4.61 7.64 9.8 8.13 18.23
Adjusted EPS (Rs.) 14.42 9.94 9.39 7.79 13.98

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity and Liabilities
Share Capital 2 7.68 10.44 10.44 13.04
Total Reserves 11.15 15.68 44.42 52.55 124.47
Borrowings 4.08 3.06 3.54 23.33 2.88
Other N/C liabilities 0.18 0.61 0.44 0.38 -0.14
Current liabilities 36.97 37.66 41.2 60.77 132.98
Total Liabilities 54.38 64.69 100.04 147.48 273.22
Assets
Net Block 11.57 13.15 17.66 39.87 53.4
Capital WIP 0 0 0 11.88 0
Intangible WIP 0 0 0 0 0
Investments 0.82 0.36 4.93 0.21 0.2
Loans & Advances 4.36 4.47 8.15 6.27 22.66
Other N/C Assets 0 0 0 1.25 4.94
Current Assets 37.62 46.71 69.3 88 192.02
Total Assets 54.38 64.69 100.04 147.48 273.22
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Profit from operations 6.11 10.06 12.78 10.56 23.63
Adjustment 2.26 3.76 0.84 4.19 2.9
Changes in Assets & Liabilities 4.04 -4.98 -14.56 -7.5 -54.16
Tax Paid -0.35 -2.53 -3.22 0 0
Operating Cash Flow 12.06 6.3 -4.15 4.59 -32.02
Investing Cash Flow -0.05 -2.97 -12.37 -30.25 -2.97
Financing Cash Flow -7.7 -0.7 21.24 21.94 69.37
Net Cash Flow 4.31 2.63 4.71 -3.71 34.37

Corporate Actions

Investors Details

PARTICULARS Mar 2025% Jun 2025% Sep 2025% Mar 2026% Sep 2026%
promoters 73.56 58.90 58.90 58.90 52.83
hanskumar shamji shah 33.78 27.05 27.05 27.05 24.26
hemant praful shah 16.61 13.30 13.30 13.30 11.93
kaushik hanskumar shah 20.14 16.13 16.13 16.13 14.47
leena hanskumar shah 0.84 0.67 0.67 0.67 0.60
naman hemant shah 0.91 0.73 0.73 0.73 0.65
neha hanskumar shah 0.74 0.60 0.60 0.60 0.53
neha hemant shah 0.53 0.43 0.43 0.43 0.38
PARTICULARS Mar 2025% Jun 2025% Sep 2025% Mar 2026% Sep 2026%
investors 26.44 41.10 41.10 41.10 47.17
bimla bajaj . - - - - 1.38
llp - - - - 0.09
mona laroia - 2.52 2.52 2.57 2.42
naresh saraaf - 0.77 1.07 1.15 1.27
renu devi hisaria - - - 2.30 2.06
singularity equity fund i... - 1.91 1.91 1.91 6.19
singularity equity fund i... - - - - 1.38
singularity large value f... - 3.83 3.83 3.83 3.44
singularity large value f... - - - 1.91 6.19
swati pokharna - 2.30 2.30 2.30 1.53
wealthwave capital trust-... - - - 3.07 2.75
bimla bajaj - - - 1.53 -
harsha venkatesh - 0.84 - 1.01 -
pm investment - 1.53 1.53 - -
renudevi hisaria - 2.30 2.30 - -
singularity large value f... - 1.91 1.91 - -
suresh zunzunwala - 2.58 2.58 - -
wealthwave capital fund - 3.07 3.07 - -
free india assurance serv... - 0.77 - - -
sachin kumar bhartiya - 0.80 - - -
upahar homfin private lim... - 0.77 - - -
carnelian structural shif... 1.11 - - - -
devendra agarwal 1.02 - - - -
gaurishankar jhalani 1.01 - - - -

Annual Reports

Title Link
Title Link
 No Annual reports exist for this company.Report us

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit and Research reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation and Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Hemant Surgical Inds Stock Price Analysis and Quick Research Report. Is Hemant Surgical Inds an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Hemant Surgical Inds. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Hemant Surgical Inds has a PE ratio of 50.1227854762322 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Hemant Surgical Inds has ROA of 8.6681% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Hemant Surgical Inds has a Current ratio of 1.444.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Hemant Surgical Inds has a ROE of 19.1774%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Hemant Surgical Inds has a Debt to Equity ratio of 0.3906 which means that the company has low proportion of debt in its capital.

  • Sales growth: Hemant Surgical Inds has reported revenue growth of 116.8351% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Hemant Surgical Inds for the current financial year is 10.1276218455489%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Hemant Surgical Inds is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Hemant Surgical Inds is Rs 12.5422. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Hemant Surgical Inds in Ticker for free. Also, one can get the intrinsic value of Hemant Surgical Inds by using Valuation Calculators, which are available with a Finology ONE subscription. 

Hemant Surgical Inds FAQs

Q1. What is Hemant Surgical Inds share price today?
Ans: The current share price of Hemant Surgical Inds is Rs 628.65.

Q2. What is the market capitalisation of Hemant Surgical Inds?
Ans: Hemant Surgical Inds has a market capitalisation of Rs 913.906224 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Hemant Surgical Inds?
Ans: The PE ratio of Hemant Surgical Inds is 50.1227854762322 and the P/B ratio of Hemant Surgical Inds is 5.83223318913172, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Hemant Surgical Inds share?
Ans: The 52-week high share price of Hemant Surgical Inds is Rs 679, and the 52-week low share price of Hemant Surgical Inds is Rs 215.

Q5. Does Hemant Surgical Inds pay dividends?
Ans: Currently, Hemant Surgical Inds does not pay dividends. Dividend yield of Hemant Surgical Inds is around 0%.

Q6. What are the face value and book value of Hemant Surgical Inds shares?
Ans: The face value of Hemant Surgical Inds shares is Rs 10, while the book value per share of Hemant Surgical Inds is around Rs 107.7889. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Hemant Surgical Inds?
Ans: Hemant Surgical Inds has a total debt of Rs 49.6647 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Hemant Surgical Inds?
Ans: The ROE of Hemant Surgical Inds is 19.1774% and ROCE of Hemant Surgical Inds is 19.6433%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Hemant Surgical Inds a good buy for the long term?
Ans: The Hemant Surgical Inds long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Hemant Surgical Inds undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Hemant Surgical Inds appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Hemant Surgical Inds’s financials?
Ans: You can review Hemant Surgical Inds’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Hemant Surgical Inds
X